Ultragenyx Pharmaceutical
RARE
RARE
218 hedge funds and large institutions have $2.52B invested in Ultragenyx Pharmaceutical in 2023 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 104 increasing their positions, 72 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
10% less funds holding
Funds holding: 241 → 218 (-23)
21% less capital invested
Capital invested by funds: $3.21B → $2.52B (-$689M)
67% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 33
Holders
218
Holding in Top 10
5
Calls
$14M
Puts
$12.7M
Top Buyers
| 1 | +$26.7M | |
| 2 | +$20.8M | |
| 3 | +$19.1M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$15M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$10.4M |
Top Sellers
| 1 | -$44.6M | |
| 2 | -$16.7M | |
| 3 | -$16.2M | |
| 4 |
Two Sigma Investments
New York
|
-$13M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$12.7M |